ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.355,14
1,01%
S&P 500
5.180,74
0,00%
Dow Jones
38.852,27
0,00%
Euro vs US Dollar
1,07796
0,11%
Bitcoin
63.531,64
0,58%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Calliditas Therapeutics AB (CALT)

  7. Calliditas Therapeutics AB (CALT) News

CALT Calliditas Therapeutics AB

20,13
0,00 (0,00%)
Vor Marktöffnung
Zuletzt aktualisiert: 15:03:40
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Calliditas Therapeutics AB CALT NASDAQ Depository Receipt
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
0,00 0,00% 20,13 15:03:40
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
20,13
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
06.5.202408:16PRNUSCalliditas announces positive topline results of Phase 2..
06.5.202408:11PRNUSCalliditas announces positive topline results of Phase 2..
24.4.202419:35PRNUSCalliditas Therapeutics' 2023 Annual Report Published
24.4.202419:26PRNUSCalliditas Therapeutics' 2023 Annual Report Published
24.4.202409:30PRNUSCalliditas Announces Positive NefIgArd Open Label Extension..
24.4.202409:26PRNUSCalliditas Announces Positive NefIgArd Open Label Extension..
18.4.202413:13PRNUSCalliditas Therapeutics Presents Additional Data Analyses..
18.4.202413:10PRNUSCalliditas Therapeutics Presents Additional Data Analyses..
09.4.202413:24PRNUSCalliditas Therapeutics to Attend Conferences in April
09.4.202413:22PRNUSCalliditas Therapeutics to Attend Conferences in April
08.4.202414:38PRNUSCalliditas Therapeutics to Present Nefecon Data at the ISN..
08.4.202414:32PRNUSCalliditas Therapeutics to Present Nefecon Data at the ISN..
08.4.202409:24PRNUSCalliditas receives notice of allowance for United States..
08.4.202409:22PRNUSCalliditas receives notice of allowance for United States..
12.3.202402:28PRNUSEverest Medicines' Partner Calliditas Therapeutics Announces..
06.3.202408:38PRNUSCalliditas announces an additional seven year orphan drug..
06.3.202408:34PRNUSCalliditas announces an additional seven year orphan drug..
01.3.202413:43PRNUSCalliditas Therapeutics to Attend Investor Conferences in..
01.3.202413:39PRNUSCalliditas Therapeutics to Attend Investor Conferences in..
21.2.202407:45PRNUSCalliditas Year-end report, January - December 2023
21.2.202407:43PRNUSCalliditas Year-end report, January - December 2023
14.2.202407:11PRNUSInvitation to the presentation of Calliditas´ Year-end..
14.2.202407:09PRNUSInvitation to the presentation of Calliditas´ Year-end..
13.2.202417:28PRNUSCalliditas provides patent update
13.2.202417:26PRNUSCalliditas provides patent update
08.1.202414:28EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08.1.202408:33PRNUSCalliditas Therapeutics provides business update ahead of JP..
08.1.202408:31PRNUSCalliditas Therapeutics provides business update ahead of JP..
07.1.202417:21PRNUSCalliditas Therapeutics appoints Maria Törnsén as President..
07.1.202417:19PRNUSCalliditas Therapeutics appoints Maria Törnsén as President..
07.1.202417:07PRNUSCalliditas to present at JP Morgan Healthcare Conference
07.1.202417:05PRNUSCalliditas to present at JP Morgan Healthcare Conference
27.12.202322:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27.12.202318:22PRNUSCalliditas refinances existing term loan with Euro 92..
27.12.202318:16PRNUSCalliditas refinances existing term loan with Euro 92..
21.12.202301:00DJNStocks to Watch: Micron, Warner Bros. Discovery, Paramount..
20.12.202323:33DJNCalliditas Therapeutics Shares Rise 33% After FDA Approves..
20.12.202323:13EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20.12.202322:34PRNUSCalliditas Therapeutics announces full FDA approval of..
20.12.202322:33PRNUSCalliditas Therapeutics announces full FDA approval of..
11.12.202315:40PRNUSCalliditas Receives Notice of Allowance for United States..
11.12.202315:38PRNUSCalliditas Receives Notice of Allowance for United States..
01.12.202309:27PRNUSCalliditas announces additions to the management team
01.12.202309:21PRNUSCalliditas announces additions to the management team
30.11.202308:55PRNUSCalliditas initiates clinical study to evaluate setanaxib in..
30.11.202308:49PRNUSCalliditas initiates clinical study to evaluate setanaxib in..
24.11.202309:13PRNUSCalliditas' partner Everest Medicines announces China NMPA's..
24.11.202309:10PRNUSCalliditas' partner Everest Medicines announces China NMPA's..
07.11.202316:31PRNUSCalliditas to present at upcoming investor conferences
07.11.202316:29PRNUSCalliditas to present at upcoming investor conferences

Kürzlich von Ihnen besucht

NASDAQ
CALT
Calliditas Therapeutics AB
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten